Caplacizumab-yhdp and Kava

• Generic Name: caplacizumab
• Dosage Forms: n.a.
• Other Brand Names: Cablivi

Caplacizumab-yhdp is a von Willebrand factor-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.

• Generic Name: kava
• Dosage Forms: n.a.
• Other Brand Names:

Kava is a plant also known as Ava, Ava Root, Awa, Intoxicating Long Pepper, Kao, Kavain, Kavapipar, Kawa, Kawapfeffer, Kew, Lawena, Malohu, Maluk, Maori Kava, Meruk, Milik, Piper methysticum, Poivre des Cannibales, Poivre des Papous, Rauschpfeffer, Rhizome Di Kava-Kava, Sakau, Tonga, Waka, Wurzelstock, Yagona, Yangona, Yaqona, Yaquon, Yongona.

Kava has been used in alternative medicine as a possibly effective aid in treating anxiety.

Other uses not proven with research have included cancer prevention, insomnia, depression, attention deficit disorder, preventing sedative withdrawal symptoms (from medicines such as Valium, Xanax, or Tranzene), and other conditions.

It is not certain whether kava is effective in treating any medical condition. Medicinal use of this product has not been approved by the FDA. Kava should not be used in place of medication prescribed for you by your doctor.

Kava is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.

Kava may also be used for purposes not listed in this product guide.